DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Uroxatral (Alfuzosin) - Fatigue - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fatigue (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Uroxatral (Alfuzosin) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Uroxatral side effects in 49 year old male

Reported by a consumer/non-health professional from United States on 2012-04-23

Patient: 49 year old male, weighing 68.5 kg (150.7 pounds)

Reactions: Weight Decreased, Confusional State, Urinary Incontinence, Abasia, Aphasia, Throat Tightness, Erectile Dysfunction, Fatigue, Chest Pain, Dizziness, Cough, Dysphagia, Drooling, Dyspnoea, Genital Discharge, Faecal Incontinence, Libido Decreased, Muscular Weakness, Tremor, Throat Irritation, Ocular Icterus, Pollakiuria, Gait Disturbance, Blood Pressure Decreased, Muscle Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Uroxatral



Possible Uroxatral side effects in 49 year old male

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: 49 year old male

Reactions: Dysphagia, Genital Discharge, Abasia, Urinary Incontinence, Faecal Incontinence, Muscular Weakness, Libido Decreased, Throat Tightness, Erectile Dysfunction, Tremor, Fatigue, Throat Irritation, Dizziness, Gait Disturbance, Muscle Disorder, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Uroxatral



Possible Uroxatral side effects in 71 year old male

Reported by a consumer/non-health professional from United States on 2011-12-15

Patient: 71 year old male, weighing 75.7 kg (166.5 pounds)

Reactions: Dyspnoea, Nausea, Abasia, Muscular Weakness, Rhinorrhoea, Drug Interaction, Reading Disorder, Somnolence, Abdominal Discomfort, Fatigue, Malaise, Pneumonia Bacterial, Insomnia, DRY Mouth, Dizziness, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aricept
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (10 mg,1 in 1 d),oral ; 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Dementia
    Start date: 2010-05-12
    End date: 2010-06-01

Aricept
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (10 mg,1 in 1 d),oral ; 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Amnesia
    Start date: 2010-05-12
    End date: 2010-06-01

Aricept
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (10 mg,1 in 1 d),oral ; 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Dementia
    Start date: 2010-06-01

Aricept
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (10 mg,1 in 1 d),oral ; 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Amnesia
    Start date: 2010-06-01

Aricept
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (10 mg,1 in 1 d),oral ; 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Dementia
    Start date: 2010-04-14
    End date: 2010-05-11

Aricept
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (10 mg,1 in 1 d),oral ; 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Amnesia
    Start date: 2010-04-14
    End date: 2010-05-11

Diamox
    Dosage: 1 mg (1 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Hypertension

Uroxatral
    Dosage: 10 mg (10 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Prostatic Disorder
    Start date: 2009-11-01

Norvasc
    Dosage: 10 mg (10 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Hypertension

Namenda
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (5 mg,2 in 1 d),oral ; 20 mg (10 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Dementia
    End date: 2011-03-09

Namenda
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (5 mg,2 in 1 d),oral ; 20 mg (10 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Dementia
    Start date: 2010-09-18

Namenda
    Dosage: 5 mg (5 mg,1 in 1 d),oral ; 10 mg (5 mg,2 in 1 d),oral ; 20 mg (10 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Dementia
    Start date: 2011-03-10

Ambien
    Indication: Insomnia

Toprol-XL
    Dosage: 200 mg (200 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Diltiazem (Diltiazem Hydrochloride) (Tablets) (Diltiazem Hydrochloride; Avodart (Dutasteride) (Tablets) (Dutasteride); Alprazolam (Alprazolam) (Tablets) (Alprazolam); Metoprolol (Metoprolol) (Tablets) (Metoprolol); Vitamin D (Vitamin D) (Vitamin D); Quinapril (Quinapril) (Tablets) (Quinapril); Zetia; Potassium Chloride; Furosemide

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017